The discovery of (R)-2-(sec-butylamino)-N(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994) -: A potent and efficacious p38α MAP kinase inhibitor

被引:23
作者
Hynes, John, Jr. [1 ]
Wu, Hong [1 ]
Pitt, Sidney [1 ]
Shen, Ding Ren [1 ]
Zhang, Rosemary [1 ]
Schieven, Gary L. [1 ]
Gillooly, Kathleen M. [1 ]
Shuster, David J. [1 ]
Taylor, Tracy L. [1 ]
Yang, XiaoXia [1 ]
McIntyre, Kim W. [1 ]
McKinnon, Murray [1 ]
Zhang, Hongjian [1 ]
Marathe, Punit H. [1 ]
Doweyko, Arthur M. [1 ]
Kish, Kevin [1 ]
Kiefer, Susan E. [1 ]
Sack, John S. [1 ]
Newitt, John A. [1 ]
Barrish, Joel C. [1 ]
Dodd, John [1 ]
Leftheris, Katerina [1 ]
机构
[1] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
关键词
D O I
10.1016/j.bmcl.2008.02.031
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel structural class of p38 alpha MAP kinase inhibitors has been identified via iterative SAR studies of a focused deck screen hit. Optimization of the lead series generated 6e, BMS-640994, a potent and selective p38 alpha inhibitor that is orally efficacious in rodent models of acute and chronic inflammation. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1762 / 1767
页数:6
相关论文
共 22 条
[1]   Deficiency of the stress kinase p38α results in embryonic lethality:: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells [J].
Allen, M ;
Svensson, L ;
Roach, M ;
Hambor, J ;
McNeish, J ;
Gabel, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :859-869
[2]   Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia [J].
Branger, J ;
van den Blink, B ;
Weijer, S ;
Madwed, J ;
Bos, CL ;
Gupta, A ;
Yong, CL ;
Polmar, SH ;
Olszyna, DP ;
Hack, CE ;
van Deventer, SJH ;
Peppelenbosch, MP ;
van der Poll, T .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :4070-4077
[3]   Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis. [J].
Choy, EHS ;
Panayi, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) :907-916
[4]   Coordinate activation of endogenous p38α, β, γ, and δ by inflammatory stimuli [J].
Fearns, C ;
Kline, L ;
Gram, H ;
Di Padova, F ;
Zurini, M ;
Han, J ;
Ulevitch, RJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (05) :705-711
[5]  
FIJEN JW, 2001, CLIN EXP IMMUNOL
[6]   Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity [J].
Fitzgerald, CE ;
Patel, SB ;
Becker, JW ;
Cameron, PM ;
Zaller, D ;
Pikounis, VB ;
O'Keefe, SJ ;
Scapin, G .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (09) :764-769
[7]  
Foster ML, 2000, DRUG NEWS PERSPECT, V13, P488
[8]  
Hale KK, 1999, J IMMUNOL, V162, P4246
[9]   Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005 [J].
Hynes, J ;
Leftheris, K .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) :967-985
[10]   Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α mitogen-activated protein kinase inhibitors [J].
Hynes, John, Jr. ;
Dyckman, Alaric J. ;
Lin, Shuqun ;
Wrobleski, Stephen T. ;
Wu, Hong ;
Gillooly, Kathleen M. ;
Kanner, Steven B. ;
Lonial, Herinder ;
Loo, Derek ;
McIntyre, Kirn W. ;
Pitt, Sidney ;
Shen, Ding Ren ;
Shuster, David J. ;
Yang, XiaoXia ;
Zhang, Rosemary ;
Behnia, Kamelia ;
Zhang, Hongjian ;
Marathe, Punit H. ;
Doweyko, Arthur M. ;
Tokarski, John S. ;
Sack, John S. ;
Pokross, Matthew ;
Kiefer, Susan E. ;
Newitt, John A. ;
Barrish, Joel C. ;
Dodd, John ;
Schieven, Gary L. ;
Leftheris, Katerina .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (01) :4-16